Respiratory Disease Clinical Trial
Official title:
Study of Variations of Pleural and Esophageal Pressures Under Mechanical Ventilation After Lung Transplantation
The primary objective of the study is to determine the correlation between mean pleural pressure and oesophageal pressure in the immediate aftermath of bi-pulmonary transplantation. In this research, oesophageal pressure will be measured by a nasogastric tube with an esophageal balloon (also suitable for feeding the patient) usually installed at the time of transplantation, pleural pressure will be measured by several Pleurocath-type catheters (Prodimed Inc, France) which the thoracic surgeon will have positioned at the end of the surgery without additional skin intrusion.
Pulmonary transplantation is a model of acute lung injury due to ischemia-reperfusion phenomena responsible in 1 in 4 patients for the occurrence of primary graft dysfunction (DPG), which penalizes graft prognosis in the short to medium term. The survival of transplant patients. Furthermore, the post-operative period is a complex period in which multiple hemorrhagic, immunological, infectious, and neuromuscular complications may arise that may require prolonged mechanical ventilation. At present, there are no data on the measurement of pressure in pleural space after pulmonary transplantation. Achieving this measurement would make it possible to adapt the settings of the ventilator to both the acute phase in the case of DPG and to a later phase in case of mechanical weaning. In the case of bi-pulmonary transplantation, before the thorax is closed, each patient benefits from the systematic placement of bilateral anterior and posterior thoracic drains to prevent the formation of fluid effusions (hemothorax, pleurisy) and / or gases (pneumothorax ) Which would impede ventilation and compromise gas exchange. These drains are gradually withdrawn during resuscitation usually after weaning mechanical ventilation ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03376204 -
Pain Mechanisms in Patients With Bronchiectasis
|
||
Not yet recruiting |
NCT05902702 -
Isotonic Saline for Children With Bronchiolitis
|
N/A | |
Recruiting |
NCT05246098 -
REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or ARI
|
||
Completed |
NCT04467190 -
Investigation of Inflammacheck to Measure Exhaled Breath Condensate Hydrogen Peroxide in Respiratory Conditions
|
||
Not yet recruiting |
NCT05374148 -
Respiratory Health Problems Among Workers in Ferrosilicon Alloys Industry in Aswan-Eygpt.
|
||
Recruiting |
NCT04502368 -
Fiberoptic Bronchoscopy and Bronchoalveolar Lavage in Critically Ill Ventilated Patients
|
||
Recruiting |
NCT05775952 -
Airway Remodeling and Rhinovirus in Asthmatics
|
||
Active, not recruiting |
NCT02681848 -
What Are the Effects of Varenicline Compared With Nicotine Replacement Therapy on Long Term Smoking Cessation and Clinically Important Outcomes?
|
||
Recruiting |
NCT06002685 -
Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention
|
N/A | |
Enrolling by invitation |
NCT03319446 -
Collection of Anonymized Samples
|
N/A | |
Recruiting |
NCT04287959 -
SWISH Trial (Strategies for Weaning Infants on Supportive High Flow)
|
N/A | |
Completed |
NCT05017727 -
Closed-loop Oxygen Control in Ventilated Infants Born at or Near Term
|
||
Completed |
NCT04607330 -
Protein Top-up Acceptability Study for Patients With Increased Protein Needs
|
N/A | |
Completed |
NCT03334916 -
A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients
|
Phase 4 | |
Completed |
NCT04649736 -
Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients
|
N/A | |
Completed |
NCT03661801 -
Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions
|
||
Enrolling by invitation |
NCT03322254 -
How Respiratory Pathogens Panel Results Affect Patients' Plan of Care
|
||
Recruiting |
NCT03937583 -
Screening for Cancer in Patients With Unprovoked VTE
|
Phase 4 | |
Not yet recruiting |
NCT06026163 -
Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress
|
Phase 2/Phase 3 | |
Completed |
NCT04581096 -
Mapping COVID-19 Spread in a Tertiary Hospital
|